Skip to main content

Bard IVC Filter Plaintiff Produces Sufficient Evidence

Bard IVC Filter Plaintiff Produces Sufficient Evidence

Bard IVC Filter Plaintiff Produces Sufficient Evidence

Introduction

The U.S. District Court, District of Arizona was approached by C. R. Bard, the defendant named in the IVC Filter litigation involving the Eclipse filter, to pass a summary judgment for failure-to-warn, misrepresentation, negligence per se, consumer fraud and unfair trade practices, and punitive damages claims made by the plaintiff. As per the court order released in mid-March, the company’s motion to dismiss the plaintiffs’ failure-to-warn and punitive damage claims was rejected.

This would be the second bellwether IVC filter lawsuit which is scheduled to go before a jury on May 15, with a final pretrial conference planned for May 4.

About 3,000 IVC filter lawsuits are pending in the consolidated action against C.R. Bard for its Recovery, G2, G2 Express, G2X, Eclipse, Meridian, and Denali IVC filters wherein plaintiffs claim that due to manufacturing and design defects, Bard filters are more dangerous than other IVC filters and that Bard failed to warn about the higher risks.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

GSK CEO Strives to Resolve Zantac Litigation Drag on Shares

Categories: Zantac

GSK Plc’s CEO has made it a priority to ensure that the majority of the company’s employees remain focused on the company's core mission, rather than the ongoing…

J&J Files Third Bankruptcy to Resolve Talc Cancer Lawsuits

Categories: Talcum

In an effort to settle tens of thousands of ovarian cancer lawsuits linked to its talcum powder products, Johnson & Johnson has once again…

Baltimore to Sue Drug Distributors Over Opioid Crisis

Categories: Opioids

Baltimore is set to go to trial in its $11 billion lawsuit against drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of contributing to the…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!